|
In the early 1980s, Le Bonheur Children's Medical Center in Memphis formed several healthcare companies to distribute clotting factor and Protropin® throughout the Southeast. Southern Health Systems, Inc., was formed in 1983 and, in 1990, Nova Factor, Inc. (NFI), was created as a wholly owned subsidiary of SHS.
Accredo Health, Incorporated, was organized in 1996 and acquired SHS and NFI In 1997, seeking additional growth within the specialty market, Accredo acquired Hemophilia Health Services, Inc., which had originally been started by a mother in response to her son's hemophilia.
Accredo became a publicly traded company in 1999. That same year, Hemophilia Health Services acquired Sunrise Health Management and entered the IVIG market. Other acquisitions soon followed, including Pharmacare Resources, Inc., and BioPartners in Care, Inc., in 2001. Accredo acquired the Specialty Pharmaceutical Services divisions and Clinical Business Solutions (now known as Proherant Health, Inc.) from Gentiva Health Services, Inc., in 2002. One of the newly acquired Gentiva divisions was renamed Accredo Therapeutics, Inc. (ATX), to focus on immunoglobulin and PAH therapies.
During this period, Accredo Health, Inc., continued to expand its role in the specialty pharmacy industry, and it was soon dispensing an elite array of biopharmaceuticals: Ceredase®, Cerezyme®, Avonex®, Synagis®, Tracleer®, Orfadin®, Actimmune®, Adagen®, Enbrel®, Flolan®, Remodulin®, Xolair®, Raptiva®, Aldurazyme®, Fabrazyme®, Aralast®, Zemaira®, and Apokyn®. In 2003, ATX was awarded accreditation by the Joint Commission on the Accreditation of Healthcare Organizations (JCAHO). That year, Accredo acquired Alpha Therapeutics Services. Home HealthCare Resources, Inc., Hemophilia Resources of America, Inc., and the pharmacy division of Pediatric Services of America, Inc., soon became part of our company.
ATX was renamed Accredo Health Group, Inc. (AHG), and, in January 2006, Hemophilia Health Services and Nova Factor were merged into Accredo Health Group, Inc., to make it easier for the healthcare community to recognize our name and to access all our services.
In 2004, Medco Health Solutions, Inc., (newly independent from Merck) and Accredo Health, Inc., announced a strategic alliance for specialty pharmacy. Accredo Health, Inc. became a wholly owned subsidiary of Medco on August 18, 2005.
Other subsidiaries of Accredo Health Group, Inc., include Critical Care Systems, and ActiveCare Network.
Accredo continues to expand its position in the specialty pharmacy industry. Starting with a directed focus on rare diseases with only 22 specialty medications in its portfolio, Accredo now dispenses close to 200 specialty drugs from approximately 83 dispensing pharmacies nationwide.
| 
